Trading of Scholar Rock was halted at 06:55 AM EST due to "News pending". Scholar Rock (SRRK) Competitors $33.75 +1.17 (+3.59%) Closing price 04:00 PM EasternExtended Trading$33.75 0.00 (0.00%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SRRK vs. ASND, VTRS, QGEN, BBIO, ROIV, ELAN, VRNA, MRNA, RVMD, and GRFSShould you be buying Scholar Rock stock or one of its competitors? The main competitors of Scholar Rock include Ascendis Pharma A/S (ASND), Viatris (VTRS), QIAGEN (QGEN), BridgeBio Pharma (BBIO), Roivant Sciences (ROIV), Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), Moderna (MRNA), Revolution Medicines (RVMD), and Grifols (GRFS). These companies are all part of the "pharmaceutical products" industry. Scholar Rock vs. Its Competitors Ascendis Pharma A/S Viatris QIAGEN BridgeBio Pharma Roivant Sciences Elanco Animal Health Verona Pharma PLC American Depositary Share Moderna Revolution Medicines Grifols Scholar Rock (NASDAQ:SRRK) and Ascendis Pharma A/S (NASDAQ:ASND) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, earnings and media sentiment. Is SRRK or ASND more profitable? Scholar Rock has a net margin of 0.00% compared to Ascendis Pharma A/S's net margin of -54.94%. Ascendis Pharma A/S's return on equity of 0.00% beat Scholar Rock's return on equity.Company Net Margins Return on Equity Return on Assets Scholar RockN/A -127.11% -90.09% Ascendis Pharma A/S -54.94%N/A -24.31% Which has higher valuation & earnings, SRRK or ASND? Scholar Rock has higher earnings, but lower revenue than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than Scholar Rock, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScholar Rock$33.19M97.75-$246.29M-$2.91-11.60Ascendis Pharma A/S$393.54M30.37-$409.12M-$5.16-37.59 Do institutionals and insiders believe in SRRK or ASND? 91.1% of Scholar Rock shares are held by institutional investors. 13.3% of Scholar Rock shares are held by insiders. Comparatively, 40.0% of Ascendis Pharma A/S shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more risk and volatility, SRRK or ASND? Scholar Rock has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Comparatively, Ascendis Pharma A/S has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Do analysts rate SRRK or ASND? Scholar Rock currently has a consensus target price of $45.60, indicating a potential upside of 35.11%. Ascendis Pharma A/S has a consensus target price of $244.36, indicating a potential upside of 25.97%. Given Scholar Rock's stronger consensus rating and higher possible upside, research analysts plainly believe Scholar Rock is more favorable than Ascendis Pharma A/S.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Scholar Rock 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 3 Strong Buy rating(s) 3.23Ascendis Pharma A/S 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to SRRK or ASND? In the previous week, Scholar Rock had 34 more articles in the media than Ascendis Pharma A/S. MarketBeat recorded 40 mentions for Scholar Rock and 6 mentions for Ascendis Pharma A/S. Ascendis Pharma A/S's average media sentiment score of 0.84 beat Scholar Rock's score of 0.54 indicating that Ascendis Pharma A/S is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Scholar Rock 7 Very Positive mention(s) 5 Positive mention(s) 8 Neutral mention(s) 8 Negative mention(s) 0 Very Negative mention(s) Positive Ascendis Pharma A/S 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryScholar Rock beats Ascendis Pharma A/S on 10 of the 17 factors compared between the two stocks. Get Scholar Rock News Delivered to You Automatically Sign up to receive the latest news and ratings for SRRK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRRK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRRK vs. The Competition Export to ExcelMetricScholar RockMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.13B$3.17B$5.77B$10.52BDividend YieldN/A2.36%5.53%4.57%P/E Ratio-11.6021.0476.4326.62Price / Sales97.75409.14535.41119.74Price / CashN/A46.3537.4661.85Price / Book8.579.7813.616.45Net Income-$246.29M-$52.73M$3.29B$271.57M7 Day Performance4.36%2.40%1.67%2.83%1 Month Performance-4.90%4.69%4.05%7.27%1 Year Performance289.27%16.28%80.70%26.07% Scholar Rock Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRRKScholar Rock4.3393 of 5 stars$33.75+3.6%$45.60+35.1%+247.0%$3.13B$33.19M-11.60140Trending NewsAnalyst ForecastGap DownTrading HaltedHigh Trading VolumeASNDAscendis Pharma A/S2.9738 of 5 stars$194.62-0.5%$244.36+25.6%+29.9%$11.97B$393.54M-37.721,017VTRSViatris1.2878 of 5 stars$9.60-3.6%$10.40+8.3%-14.0%$11.61B$14.74B-3.3132,000High Trading VolumeQGENQIAGEN4.3617 of 5 stars$45.39+0.2%$49.69+9.5%+4.7%$10.07B$1.98B26.825,765BBIOBridgeBio Pharma4.4974 of 5 stars$51.47+0.5%$63.94+24.2%+92.7%$9.79B$221.90M-12.58400ROIVRoivant Sciences3.4223 of 5 stars$13.95-0.9%$17.67+26.6%+24.8%$9.61B$29.05M-19.93860Trending NewsInsider TradeAnalyst RevisionELANElanco Animal Health2.5844 of 5 stars$18.63+0.5%$17.33-6.9%+35.6%$9.21B$4.44B21.669,000VRNAVerona Pharma PLC American Depositary Share2.0358 of 5 stars$106.37-0.1%$109.00+2.5%+254.3%$9.17B$42.28M-107.4430Positive NewsMRNAModerna4.4611 of 5 stars$23.88+1.6%$41.81+75.1%-59.6%$9.15B$3.24B-3.175,800Trending NewsRVMDRevolution Medicines4.2884 of 5 stars$46.20-0.8%$73.67+59.5%-2.2%$8.70B$11.58M-10.27250GRFSGrifols3.9109 of 5 stars$9.63-2.5%$10.30+7.0%+8.4%$6.79B$7.81B8.2323,822 Related Companies and Tools Related Companies ASND Competitors VTRS Competitors QGEN Competitors BBIO Competitors ROIV Competitors ELAN Competitors VRNA Competitors MRNA Competitors RVMD Competitors GRFS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRRK) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scholar Rock Holding Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Scholar Rock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRRK Stock Alerts